Form 4 Intellia Therapeutics, For: Jun 17 Filed by: Verwiel Frank

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Form 4 Intellia Therapeutics, For: Jun 17 Filed by: Verwiel Frank

Stifel on Intellia Therapeutics (NTLA): 'Positive Ph.3 HELIOS-B data this morning validates the NTLA-2001 approach'

June 24, 2024 12:15 PM EDT

Stifel analyst Dae Gon Ha reiterated a Buy rating and $80.00 price target on Intellia Therapeutics (NASDAQ: NTLA).

The analyst comments "Positive Ph.3 HELIOS-B data this morning validates the NTLA-2001 approach and with the Ph.3 MAGNITUDE study ongoing, should be seen... More

Baird on Intellia Therapeutics (NTLA): 'we anticipate enthusiasm will wane'

June 24, 2024 9:49 AM EDT

Baird analyst Jack Allen reiterated a Neutral rating and $24.00 price target on Intellia Therapeutics (NASDAQ: NTLA).

The analyst comments "No change to outlook on competitor's clinical data. This morning, Alnylam (ALNY, not covered) announced positive top-line results from the HELIOS-B study of their... More